BioNTech Variant-adapted COVID-19 Vaccines Do Well In Q3
BioNTech's Q3 revenue surged to €1.244 billion, reflecting early COVID-19 vaccine approvals. Net profit rose to €198.1 million, and full-year guidance adjusted downward.
read more
Market Clubhouse Morning Memo – November 4th, 2024 (Trade Strategy For SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META And TSLA)
Good Morning Traders! In today's Market Clubhouse Morning Memo, we will discuss SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, and TSLA.
read more
Why Lilium (LILM) Stock Is Falling
Lilium shares are trading lower by 11% Monday morning. The company received a Nasdaq notice of the suspension and delisting of its Class A shares and warrants.
read more
Why NioCorp Developments (NB) Stock Is Trading Lower
NioCorp Developments shares are trading lower by 12.5% Monday morning. The company announced the pricing of a public and a private offering.
read more
Oil Prices Spike By Over 3% As OPEC+ Delays Production Increases Ahead Of US Elections: 5 Energy ETFs To Watch Monday
The Biden-Harris administration has imposed extensive sanctions on Russia; a second Trump administration would likely nix those sanctions.
read more
$61,000 Is Bitcoin’ Line In The Sand For ETF Demand To Remain Steady, Says Analyst
CryptoQuant founder and CEO Ki Young Ju, on Monday highlighted that demand for Bitcoin spot ETFs has been robust, with significant net inflows at price levels above $61,000.
read more
End Of An Era – AI Propels Nvidia To Replace Struggling Intel In Dow Index
Nvidia Corp (NASDAQ: NVDA) to replace Intel Corp (NASDAQ: INTC) on Dow Jones Industrial Average after 25 years, reflecting market shifts and Intel's setbacks.
read more
Trump-Linked Phunware’s Leadership Shuffle Continues: CFO Joins CEO In Exit Queue
Enterprise solutions company Phunware shares down premarket due to CFO's resignation, unrelated to company operations.
read more
Expert Outlook: Visa Through The Eyes Of 23 Analysts
Latest Ratings for V
DateFirmActionFromTo Jan 2022BarclaysMaintainsOverweight Jan 2022WedbushMaintainsOutperform Jan 2022Raymond JamesMaintainsOutperform
View More Analyst Ratings for V
View the Latest Analyst Ratings
read more
